Disulfide connectivity of human immunoglobulin G2 structural isoforms

Biochemistry

Volumn 47, Issue 28, 2008, Pages 7496-7508

  Martinez, Theresa ^a   Guo, Amy ^a   Allen, Martin J ^a   Han, Mei ^a   Pace, Danielle ^a   Jones, Jay ^a,b   Gillespie, Ron ^a   Ketchem, Randal R ^a   Zhang, Yuling ^a   Balland, Alain ^a  

^a AMGEN INC   (United States)

^b SEATTLE GENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COVALENT COMPLEXES; DISULFIDE BRIDGES; HEAVY CHAIN (VH); HUMAN IMMUNOGLOBULIN (HUIG); ISOFORMS; LIGHT CHAIN (LC); STRUCTURAL MODEL (SM);

MODEL STRUCTURES;

CYSTEINE; FC RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G2;

ALKYLATION; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; HEAVY CHAIN; IMMUNOGLOBULIN STRUCTURE; LIGHT CHAIN; PRIORITY JOURNAL; REDUCTION; SITE DIRECTED MUTAGENESIS;

DISULFIDES; ELECTROPHORESIS, CAPILLARY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MODELS, MOLECULAR; PEPTIDE MAPPING; PROTEIN CONFORMATION; PROTEIN ISOFORMS;

EID: 47249108616     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800576c     Document Type: Article

References (29)

1. Poljak, R. J., Amzel, L. M., Chen, B. L., Phizakerley, R. P., and Saul, F. (1974) The three-dimensional structure of the Fab′ fragment of a human myeloma immunoglobulin at 2.0 angstrom resolution. Proc. Natl. Acad. Sci. U.S.A. 71, 3440-3444.
2. Deisenhofer, J. (1981) Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 angstrom resolution. Biochemistry 20, 2361-2370.
3. Davies, D. R., and Chacko, S. (1993) Antibody structure. Acc. Chem. Res. 26, 421-427.
4. Padlan, E. A. (1996) X-ray crystallography of antibodies. Adv. Protein Chem. 49, 57-133.
5. Aalberse, R. C., and Schuurman, J. (2002) IgG4 breaking the rules. Immunology 105, 9-19.
6. van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martinez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vinck, T., Aarden, L. A., de Bates, M. H., van de Winkel, J. G., Aalberse, R. C., and Parren, P. W. (2007) Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317, 1554-1557.
7. Kabat, E. A., Wu, E. A., Perry, T. T., Gottesman, H. M. K. S., and Foeller, C. (1991) in Sequences of Proteins of Immunological Interest, 5th ed., U.S. Public Health Service, NIH, Washington, DC.
8. Harris, L. J., Larson, S. B., Hasel, K. W., and McPherson, A. (1997) Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36, 1581-1597.
9. Harris, L. J., Skaletsky, E., and McPherson, A. (1998) Crystallographic structure of an intact IgG1 monoclonal antibody. J. Mol. Biol. 275, 861-872.
10. Saphire, E. O., Stanfield, R. L., Crispin, M. D. M., Parren, P. W. H. I., Rudd, P. M., Dwek, R. A., Burton, D. R., and Wilson, I. A. (2002) Contrasting IgG structures reveal extreme asymmetry and flexibility. J. Mol. Biol. 319, 9-18.
11. Milstein, C., and Frangione, B. (1971) Disulphide bridges of the heavy chain of human immunoglobulin G2. Biochem. J. 121, 217-225.
12. Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., Bondarenko, P. V., Speed Ricci, M., Dillon, T. M., and Balland, A. (2008) Human IgG2 antibodies display disulfide mediated structural isoforms, J. Biol. Chem. . (published online).
13. Dillon, T. M., Speed Ricci, M., Vezina, C., Flynn, G. C., Liu, Y. D., Rehder, D. S., Plant, M., Henkle, B., Li, Y., Deechongkit, S., Varnum, B., Wypych, J., Balland, A., and Bondarenko, P. V. (2008) Structural and functional characterization of disulfide isoforms of the human IgG2 subclass, J. Biol. Chem. . (published online).
14. Brady, L. J., Valliere-Douglass, J. F., Martinez, T., and Balland, A. (2008) Molecular mass analysis of antibodies by online SEC-MS. J. ASMS 19, 502-509.
15. H domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine anti-tumor antibodies and their engineered human constructs. Proteins 29, 161-171.
16. Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., and Wilson, I. A. (2001) Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 293, 1155-1159.
17. Guo, A., Han, M., Martinez, T., Ketchem, R., Jochheim, C., Novick, S., and Balland, A. (2008) Electrophoretic evidence for the presence of structural isoforms specific for the IgG2 isotype, Electrophoresis (in press).
18. Jefferis, R. (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 21, 11-16.
19. Bures, E. J., Hui, J. O., Chow, D. T., Katta, V., Rohde, M. F., Zeni, L., Rosenfeld, R. D., Stark, K. L., and Haniu, M. (1998) Determination of disulfide structure in Agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry 37, 12172-12177.
20. Gray, W. R. (1993) Disulfide structures of highly bridged peptides: a new strategy for analysis. Protein Sci. 2, 1732-1748.
21. Roux, K. H., Strelets, L., and Michaelsen, T. E. (1997) Flexibility of IgG subclasses. J. Immunol. 159, 3372-3382.
22. Marchalonis, J. J., Schluter, S. F., Bernstein, R. M., Shen, S., and Edmunson, A. B. (1998) Phylogenetic emergence and molecular evolution of the immunoglobulin family. Adv. Immunol. 70, 417-506.
23. Sandin, S., Ofwerstedt, L. G., Wikstrom, A. C., Wrange, O., and Skoglund, U. (2004) Structure and flexibility of individual Immunoglobulin G molecules in solution. Structure 12, 409-415.
24. Yoo, E. M., Wims, L. A., Chan, L. A., and Morrison, S. L. (2003) Human IgG2 can form covalent dimers. J. Immunol. 170, 3134-3138.
25. Jefferis, R., and Lund, J. (2002) Interaction sites on human IgG-Fc for FcγR: current models. Immunol. Lett. 82, 57-65.
26. Chappel, M. S., Insenman, D. E., Everett, M., Xu, R., Dorrington, K. J., and Klein, M. H. (1991) Identification of the Fcγ receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc. Natl. Acad. Sci. U.S.A. 88, 9036-9040.
27. H2 influence the relative abilities of IgG2 and IgG3 to activate complement. Mol. Immunol. 34, 1019-1029.
28. Armour, K. L., van de Winkel, J. G. J., Williamson, L. M., and Clark, M. R. (2003) Differential binding to human FcγRIIa and FcγRIIb by human IgG wild type and mutant antibodies. Mol. Immunol. 40, 585-593.
29. Woof, J. M., and Burton, D. R. (2004) Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. 4, 1-11.